Clinical, echocardiographic and procedural characteristic of the study population.

Abbreviations: BMI – body mass index; TE - thromboembolic events, VKA – vitamin K antagonists; ACEI – angiotensin converting enzyme inhibitors; ARB – angiotensin receptor blockers; non-OAC – anticoagulation with aspirin, clopidogrel or low molecular weight heparins, LAD – left atrial diameter, IVSd – interventricular septum end-diatolic, LV-EDd – left ventricular end-diastolic diameter, EF – ejection fraction, LAA – left atrial appendage, SR – sinus rhythm, CV – electrical cardioversion, ACT – activated clotting time.Data mean ± SD, median [interquartile range], or actual numbers/%.Clinical, echocardiographic and procedural characteristic of the study population.

缩写说明：BMI（body mass index）为体重指数；TE（thromboembolic events）为血栓栓塞事件；VKA（vitamin K antagonists）为维生素K拮抗剂；ACEI（angiotensin converting enzyme inhibitors）为血管紧张素转换酶抑制剂；ARB（angiotensin receptor blockers）为血管紧张素Ⅱ受体拮抗剂；non-OAC为采用阿司匹林、氯吡格雷或低分子肝素的抗凝治疗；LAD（left atrial diameter）为左心房内径；IVSd（interventricular septum end-diastolic）为舒张末期室间隔厚度；LV-EDd（left ventricular end-diastolic diameter）为左心室舒张末期内径；EF（ejection fraction）为射血分数；LAA（left atrial appendage）为左心耳；SR（sinus rhythm）为窦性心律；CV（electrical cardioversion）为电复律；ACT（activated clotting time）为活化凝血时间。数据以平均值±标准差、中位数[四分位间距]或实际例数/百分比形式呈现。本研究人群的临床、超声心动图及操作相关特征。